Amitriptyline Market
According to Intent Market Research, the Amitriptyline Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 6.1% to touch USD 2.2 billion by 2030. The Amitriptyline Market is dominated by key players such as, Eli Lilly and Co., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Zydus Cadila, and Dr. Reddy's Laboratories Ltd..